Corrigendum—Consent to the Distribution of New Medicines - 2020-go305- New Zealand Gazette

Notice Type: Departmental
Notice Title: Corrigendum—Consent to the Distribution of New Medicines

Notice Type: Departmental

Publication Date: 22 Jan 2020

Tags: Medicines Act Consent to the distribution of new medicines Health

Notice Number: 2020-go305

Title: View PDF
File Type and Size: PDF (34 KB)

In the notice with the above heading, published in the New Zealand Gazette, 16 January 2020, Notice No. 2020-go153.

This corrigendum amends the notice by replacing the entries:

*Product:*	Amoxiclav-Duo
Active Ingredients:	Amoxicillin trihydrate 91.84mg/mL Potassium clavulanate 27.154mg/mL
Dosage Form:	Powder for oral suspension
New Zealand Sponsor:	Devatis Limited
Manufacturer:	Deva Holding AS, Tekirdag, Turkey

*Product:*	Amoxiclav-Forte
Active Ingredients:	Amoxicillin trihydrate 57.4mg/mL Potassium clavulanate 29.776mg/mL
Dosage Form:	Powder for oral suspension
New Zealand Sponsor:	Devatis Limited
Manufacturer:	Deva Holding AS, Tekirdag, Turkey

With:

*Product:*	Amoxiclav Devatis Duo
Active Ingredients:	Amoxicillin trihydrate 91.84mg/mL Potassium clavulanate 27.154mg/mL
Dosage Form:	Powder for oral suspension
New Zealand Sponsor:	Devatis Limited
Manufacturer:	Deva Holding AS, Tekirdag, Turkey

*Product:*	Amoxiclav Devatis Forte
Active Ingredients:	Amoxicillin trihydrate 57.4mg/mL Potassium clavulanate 29.776mg/mL
Dosage Form:	Powder for oral suspension
New Zealand Sponsor:	Devatis Limited
Manufacturer:	Deva Holding AS, Tekirdag, Turkey

Dated this 21st day of January 2020.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).